Kintor Pharmaceutical Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was CNY 1,060.82 million compared to CNY 954.37 million a year ago. Basic loss per share from continuing operations was CNY 2.47 compared to CNY 2.53 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.3 HKD | +3.17% | +7.44% | -20.25% |
Jun. 04 | Kintor Pharma Receives Standard Cosmetic Ingredient Name for KX-826 Product | MT |
Jun. 04 | Kintor Pharmaceutical Limited Announces Kx-826 Receives the Inci Designation | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.25% | 70.88M | |
+16.93% | 124B | |
+17.01% | 109B | |
-7.23% | 23.84B | |
+1.98% | 22.42B | |
-14.29% | 17.5B | |
-6.79% | 16.61B | |
-37.63% | 16.43B | |
+2.17% | 13.4B | |
+24.42% | 11.47B |
- Stock Market
- Equities
- 9939 Stock
- News Kintor Pharmaceutical Limited
- Kintor Pharmaceutical Limited Reports Earnings Results for the Full Year Ended December 31, 2023